Sturgeon later joined GSK’s new CEO Emma Walmsley for a tour of the new building where active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta inhaler will be produced.
PLANT
First Minister of Scotland Nicola Sturgeon applauds as she visits to officially open GlaxoSmithKline’s (GSK’s) new production building in Montrose, Scotland, yesterday.
Sturgeon later joined GSK’s new CEO Emma Walmsley for a tour of the new building where active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta inhaler will be produced.
Sturgeon later joined GSK’s new CEO Emma Walmsley for a tour of the new building where active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta inhaler will be produced.
